BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11480750)

  • 1. Evolution of the evidence-based Papanicolaou smear.
    Mashburn J
    J Midwifery Womens Health; 2001; 46(3):181-9. PubMed ID: 11480750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro adjuncts to the pap smear.
    Felix JC; Amezcua C
    Obstet Gynecol Clin North Am; 2002 Dec; 29(4):685-99, vii. PubMed ID: 12509092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The postpartum Papanicolaou smear.
    Weiss BD; Senf JH; Udall W
    J Am Board Fam Pract; 1989; 2(1):4-9. PubMed ID: 2538045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for human papillomavirus in women with abnormal pap smear results.
    McCaffery KJ; Waller J; Forrest S; Wardle J
    JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal Pap smears, ASCUS still ob/gyn puzzle.
    Titus K
    JAMA; 1996 Oct; 276(13):1014-6. PubMed ID: 8847749
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer.
    Shapiro S; Carrara H; Allan BR; Hoffman M; Rosenberg L; Kelly JP; Cooper DD; Williamson AL
    Cancer Causes Control; 2003 Dec; 14(10):953-7. PubMed ID: 14750534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
    Jin XW; Xu H
    Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papanicolaou smear screening augmented by a magnified chemiluminescent exam.
    Mann W; Lonky N; Massad S; Scotti R; Blanco J; Vasilev S
    Int J Gynaecol Obstet; 1993 Dec; 43(3):289-96. PubMed ID: 7907040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
    Melnikow J; Chan BK; Stewart GK
    Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
    Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
    Stoler MH
    J Histochem Cytochem; 2001 Sep; 49(9):1197-8. PubMed ID: 11511693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening.
    Lörincz AT
    J Obstet Gynaecol Res; 1996 Dec; 22(6):629-36. PubMed ID: 9037955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.
    Jacobs MV; Zielinski D; Meijer CJ; Pol RP; Voorhorst FJ; de Schipper FA; Runsink AP; Snijders PJ; Walboomers JM
    Br J Cancer; 2000 Apr; 82(8):1421-6. PubMed ID: 10780521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
    Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
    Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of simultaneous cervical cytology, HPV testing, and colposcopy.
    Hockstad RL
    Fam Pract Res J; 1992 Mar; 12(1):53-60. PubMed ID: 1312758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening program integrating Pap smear and HPV DNA testing: a population-based study.
    Chao A; Hsu KH; Lai CH; Huang HJ; Hsueh S; Lin SR; Jung SM; Chao FY; Huang SL; Huang CC; Yang JE; Chang TC
    Int J Cancer; 2008 Jun; 122(12):2835-41. PubMed ID: 18338752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescreening of cervical Papanicolaou smears using PAPNET.
    Greenberg MD
    JAMA; 1998 Jun; 279(22):1785-6; author reply 1787-8. PubMed ID: 9628705
    [No Abstract]   [Full Text] [Related]  

  • 19. [What to do after an abnormal pap smear test result?].
    Gondry J; Muszynski C; Chevreau J
    Rev Prat; 2014 Jun; 64(6):786-8. PubMed ID: 25090761
    [No Abstract]   [Full Text] [Related]  

  • 20. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.